Cargando…
Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enteroc...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014772/ https://www.ncbi.nlm.nih.gov/pubmed/17678541 http://dx.doi.org/10.1186/1471-2334-7-88 |
_version_ | 1782136564693860352 |
---|---|
author | Junior, Moacyr S Correa, Luci Marra, Alexandre R Camargo, Luis FA Pereira, Carlos AP |
author_facet | Junior, Moacyr S Correa, Luci Marra, Alexandre R Camargo, Luis FA Pereira, Carlos AP |
author_sort | Junior, Moacyr S |
collection | PubMed |
description | BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enterococci). The aim of this work was to analyze the use of vancomycin and the risk factors associated with inappropriate treatment. METHODS: A prospective survey was conducted on all patients receiving vancomycin between 1(st )March 2002 and 30(th )September 2002 in a university-school hospital. Appropriateness of vancomycin use was assessed, according to the criteria established by the Centers for Disease Control and Prevention (CDC), at two time points: first, at the beginning of therapy, and second, continuing after 72 hours. RESULTS: A total of 557 patients received vancomycin. Three hundred seventy-four (67.1%) were under 60 years old, 374 (67.1%) had prolonged stays (>two weeks) in hospital, and 455 (81.7%) were in the intensive care unit (ICU). Two hundred sixty-three patients (47.2%) had some invasive device. In 324 (58.2%) patients the duration of vancomycin treatment was up to two weeks. Vancomycin was inappropriately used in 65.7% during the first 24 hours and in 67% at the 72 hours point according to CDC criteria [4]. The inappropriateness of vancomycin use during the first 24 hours was related to: patients aged less than 60 (OR 1.7; CI 95% 1.1–2.5), non-ICU patients (OR 1.5; CI 95% 1.0–2.4) and patients without neutropenia (OR 7.5; CI 95% 2.4–22.7). At 72 hours, the inappropriateness of vancomycin use was related to: patients aged less than 60 (OR 1.5; CI 95% 1.0–2.3), non-ICU patients (OR 1.7; CI 95% 1.1–2.7) and patients without neutropenia (OR 8.0; CI 95% 2.6–24.3). CONCLUSION: Vancomycin was abused. Patients aged less than 60, non-ICU patients and those who did not present neutropenia were the principal groups at risk of inappropriate use. |
format | Text |
id | pubmed-2014772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20147722007-10-11 Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study Junior, Moacyr S Correa, Luci Marra, Alexandre R Camargo, Luis FA Pereira, Carlos AP BMC Infect Dis Research Article BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enterococci). The aim of this work was to analyze the use of vancomycin and the risk factors associated with inappropriate treatment. METHODS: A prospective survey was conducted on all patients receiving vancomycin between 1(st )March 2002 and 30(th )September 2002 in a university-school hospital. Appropriateness of vancomycin use was assessed, according to the criteria established by the Centers for Disease Control and Prevention (CDC), at two time points: first, at the beginning of therapy, and second, continuing after 72 hours. RESULTS: A total of 557 patients received vancomycin. Three hundred seventy-four (67.1%) were under 60 years old, 374 (67.1%) had prolonged stays (>two weeks) in hospital, and 455 (81.7%) were in the intensive care unit (ICU). Two hundred sixty-three patients (47.2%) had some invasive device. In 324 (58.2%) patients the duration of vancomycin treatment was up to two weeks. Vancomycin was inappropriately used in 65.7% during the first 24 hours and in 67% at the 72 hours point according to CDC criteria [4]. The inappropriateness of vancomycin use during the first 24 hours was related to: patients aged less than 60 (OR 1.7; CI 95% 1.1–2.5), non-ICU patients (OR 1.5; CI 95% 1.0–2.4) and patients without neutropenia (OR 7.5; CI 95% 2.4–22.7). At 72 hours, the inappropriateness of vancomycin use was related to: patients aged less than 60 (OR 1.5; CI 95% 1.0–2.3), non-ICU patients (OR 1.7; CI 95% 1.1–2.7) and patients without neutropenia (OR 8.0; CI 95% 2.6–24.3). CONCLUSION: Vancomycin was abused. Patients aged less than 60, non-ICU patients and those who did not present neutropenia were the principal groups at risk of inappropriate use. BioMed Central 2007-08-01 /pmc/articles/PMC2014772/ /pubmed/17678541 http://dx.doi.org/10.1186/1471-2334-7-88 Text en Copyright © 2007 Junior et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Junior, Moacyr S Correa, Luci Marra, Alexandre R Camargo, Luis FA Pereira, Carlos AP Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title | Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title_full | Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title_fullStr | Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title_full_unstemmed | Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title_short | Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
title_sort | analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014772/ https://www.ncbi.nlm.nih.gov/pubmed/17678541 http://dx.doi.org/10.1186/1471-2334-7-88 |
work_keys_str_mv | AT juniormoacyrs analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy AT correaluci analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy AT marraalexandrer analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy AT camargoluisfa analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy AT pereiracarlosap analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy |